CLASS II ONGOING Device recall · Reported 12 Jun 2024 · FDA Enforcement Report

IBA Proton Therapy System - Proteus recalled by Ion Beam Applications

Ion Beam Applications is recalling IBA Proton Therapy System - Proteus 235 - Designed to produce and deliver a proton beam, distributed nationwide in the US. The recall was initiated on 10 May 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: SAT140: (01)05404013814015(11)190507(21)SAT140 SAT136: (01)05404013801138(11)201105(21)SAT136 Serial Numbers: SAT136, SAT140 PTS-11 versions from PTS-11.1 and PTS-12 versions, with C230 accelerator
Quantity recalled2 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1945-2024
FDA event ID
94576
Recalling firm
Ion Beam Applications, Ottignies-Louvain-La-Neuve, N/A
Classification
Class II
Status
Ongoing
Recall initiated
10 May 2024
FDA classified
3 Jun 2024
Reported
12 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 May 2024Recall initiated by company
3 Jun 2024Classified by FDA+24 days
12 Jun 2024Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances

Product as listed by the FDA

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

Where it was distributed

Worldwide - US Nationwide distribution in the state of Virginia and the country of India.

Nationwide Virginia

Questions about this recall

Is IBA Proton Therapy System - Proteus 235 - Designed to produce and deliver a proton beam recalled?

Yes. Ion Beam Applications recalled IBA Proton Therapy System - Proteus 235 - Designed to produce and deliver a proton beam on 10 May 2024. The recall is Class II and its status is Ongoing. Recall number Z-1945-2024.

Why was it recalled?

Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances

Which lots are affected?

UDI: SAT140: (01)05404013814015(11)190507(21)SAT140 SAT136: (01)05404013801138(11)201105(21)SAT136 Serial Numbers: SAT136, SAT140 PTS-11 versions from PTS-11.1 and PTS-12 versions, with C230 accelerator

Where was it sold?

Worldwide - US Nationwide distribution in the state of Virginia and the country of India.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ion Beam Applications

All 36

Other Other Medical Devices recalls

All 13,778